• 2014 Citations
  • 27 h-Index
20032019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Toru Miyoshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Percutaneous Coronary Intervention Medicine & Life Sciences
Coronary Artery Disease Medicine & Life Sciences
Eicosapentaenoic Acid Medicine & Life Sciences
Coronary Vessels Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Serum Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Fatty Acid-Binding Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 2014 Citations
  • 27 h-Index
  • 117 Article
  • 3 Letter
  • 2 Comment/debate
  • 2 Review article
1 Citation (Scopus)

Brachial intima-media thickness is associated with coronary artery atherosclerosis in patients with diabetes mellitus

Ono, T., Miyoshi, T., Ohno, Y., Osawa, K., Takaya, Y., Miki, T., Ichikawa, K. & Itoh, H., Jan 1 2019, In : Heart and Vessels.

Research output: Contribution to journalArticle

Coronary Artery Disease
Coronary Vessels
Diabetes Mellitus
Arm
Dilatation
Open Access
Renal Artery
Angioplasty
Proteinuria
Angiotensin-Converting Enzyme Inhibitors
Kidney
Open Access
hypertension
Epoprostenol
Drug Delivery Systems
Pulmonary Hypertension
Nanoparticles
1 Citation (Scopus)

Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study

Miki, T., Miyoshi, T., Kotani, K., Kohno, K., Asonuma, H., Sakuragi, S., Koyama, Y., Nakamura, K. & Itoh, H., Apr 1 2019, In : Atherosclerosis. 283, p. 1-6 6 p.

Research output: Contribution to journalArticle

HDL Lipoproteins
Multicenter Studies
Coronary Vessels
Prospective Studies
Atherosclerosis
1 Citation (Scopus)
Open Access
Neprilysin
Angiotensin Receptors
Cardiomegaly
Isoproterenol
Valsartan